MEDEXUS PHARMA
Medexus Pharma is a fully integrated specialty pharmaceutical company located in Chicago.
MEDEXUS PHARMA
Industry:
Biotechnology Medical Device Pharmaceutical
Founded:
2012-01-01
Address:
Chicago, Illinois, United States
Country:
United States
Website Url:
http://www.medexus.com
Total Employee:
51+
Status:
Active
Contact:
312-854-0500
Total Funding:
42.12 M USD
Technology used in webpage:
SPF SSL By Default Microsoft Exchange Online Amazon Office 365 Mail IPv6 Cloudflare JS CDN JS Amazon Virginia Region Amazon Route 53
Similar Organizations
Checkmate Pharmaceuticals
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-06-22 | Aptevo Therapeutics | Aptevo Therapeutics acquired by Medexus Pharma | N/A |
Investors List
MidCap Financial
MidCap Financial investment in Post-IPO Debt - Medexus Pharma
Official Site Inspections
http://www.medexus.com Semrush global rank: 4 M Semrush visits lastest month: 3.1 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Medexus Pharma"
Medexus Pharmaceuticals, Inc. (MDP)
Oct 29, 2024 · Medexus Pharmaceuticals, Inc. is a leading innovative specialty pharmaceutical company with a highly scalable North American business model based on our fully integrated …See details»
About :: Medexus Pharmaceuticals, Inc. (MDP)
We have a strong North American commercial platform and we currently operate through two unique segments: Medexus Pharma Canada and Medexus Pharma USA. Better Lives through Innovative Medicine. To become the most trusted …See details»
Company Information :: Medexus Pharmaceuticals, Inc. (MDP)
Medexus Pharmaceuticals, Inc. is a leading innovative specialty pharmaceutical company with a strong North American commercial platform. Our product portfolio features leading products …See details»
MEDEXUS PHARMACEUTICALS INC. - Drug and Health Products …
Information on drug and health products authorized by Health Canada.See details»
Medexus and pan-Canadian Pharmaceutical Alliance (pCPA
Nov 18, 2024 · Medexus is committed to continuing to work with participating provincial, territorial, and federal government organizations to make Trecondyv® available as soon as possible …See details»
Medexus Pharmaceuticals Inc - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Medexus Pharmaceuticals Inc of Bolton, ON. Get the latest business insights from Dun & Bradstreet.See details»
Medexus Pharmaceuticals - LinkedIn
Leading North American Specialty Pharmaceutical Company focused on hematology, rheumatology, auto-immune disease, specialty oncology and pediatrics. Wow! What a …See details»
Medexus Welcomes Two New Board Members - Financial Post
Feb 6, 2023 · Dr Garges and Mr Taddese were elected to fill two newly created directorships with effect as of February 6, 2023 and will initially serve until the next annual meeting of Medexus …See details»
Medexus Pharmaceuticals - Overview, News & Similar companies
Nov 10, 2023 · Medexus Pharmaceuticals contact info: Phone number: (514) 762-2626 Website: www.medexus.com What does Medexus Pharmaceuticals do? Medexus Pharmaceuticals is a …See details»
Board of Directors :: Medexus Pharmaceuticals, Inc. (MDP)
Medexus Pharmaceuticals, Inc.’s board of directors’ members have extensive experience serving in various leadership roles across numerous companies.See details»
Medexus Pharmaceuticals - Crunchbase Company Profile & Funding
Medexus Pharmaceuticals is a commercial platform providing products and services to differentiated companies with a portfolio of valuable orphan and rare disease products. They …See details»
Medexus Inc. - LinkedIn
Medexus Inc. | 445 followers on LinkedIn. Medexus has a strong Canadian position as an innovator with new and existing products. Key areas include: Rheumatology, Women’s health, …See details»
Medexus Pharma - Crunchbase Company Profile & Funding
Medexus Pharma is a pharmaceutical company that offers products for rare diseases. They provide healthcare products that address a variety of diseases, including rheumatology, auto …See details»
Medexus and pan-Canadian Pharmaceutical Alliance (pCPA) …
Nov 18, 2024 · Medexus is committed to continuing to work with participating provincial, territorial, and federal government organizations to make Trecondyv® available as soon as possible …See details»
Medexus Announces Expanded Availability of Gleolan® in Canada
Feb 25, 2021 · TORONTO and CHICAGO and MONTREAL, Feb. 25, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSXV: …See details»
Medexus Announces Strongest Quarter in Company History with …
Nov 8, 2022 · Record total revenue of $27.7 million, a year-over-year increase of 55%, and a quarter-over-quarter increase of 20%. This represents the strongest fiscal quarter in …See details»
MEDXF Stock Price Quote | Morningstar
Nov 18, 2024 · See the latest Medexus Pharmaceuticals Inc stock price (MEDXF:PINX), related news, valuation, dividends and more to help you make your investing decisions.See details»
Corporate Governance :: Medexus Pharmaceuticals, Inc. (MDP)
Ken d’Entremont is the founder, president, and CEO of Medexus Inc. Previously, he was the general manager and vice president of business development at Sanofi, where he led the in …See details»
Log in to your Okta org
Not yet an Okta customer? If you don’t have an Okta organization or credentials, use the Okta Digital Experience Account to get access to Learning Portal, Help Center, Certification, …See details»
Medexus Announces Strong Fiscal Q2 2025 Results
Nov 7, 2024 · Fiscal Q2 2025 revenue of $26.3 million, net income of $0.1 million, operating income of $1.6 million, and Adjusted EBITDA* of $6.0 million. Management to host conference …See details»